Needham & Company, Freedom Capital, and Truist Financial issued rating and price target updates for Entegris stock.
1 report, 1 independent
Updated Wed 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Needham & Company, Freedom Capital, and Truist Financial issued rating and price target updates for Entegris stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Entegris
American supplier
-
Needham & Company
American independent investment bank and asset management firm
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
-
Freedom Capital
company in the Czech Republic
Related events
- Truist Financial raised its target price on Teva Pharmaceutical Industries Ltd. stock.
- Citi maintained a Buy rating on Entegris stock, while Entegris announced R&D spending related to the Trump Administration.
- Citigroup reissued a market outperform rating and Needham lifted its target price for Alkami Technology Inc.